Therapeutic manipulation of T cell chemotaxis in transplantation

Adam C Yopp1, Nancy R Krieger, Jordi C Ochando

  • 1Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1104, New York, New York 10029-6574, USA.

Insights

T cell migration involves molecular signals like integrins and sphingosine 1-phosphate receptors. Understanding these pathways is key for preventing transplant rejection and promoting immune tolerance.

Area of Science:

  • Immunology
  • Cellular Biology
  • Transplantation Immunology

Background:

  • T cell migration and trafficking are crucial for immune responses and are regulated by defined cellular processes.
  • Molecular mediators including integrins, selectins, chemokines, and chemokine receptors control these cellular events.
  • Emerging research highlights the role of sphingosine 1-phosphate receptors and their ligands in modulating T cell migration.

Purpose of the Study:

  • To review the molecular mechanisms regulating T cell migration and trafficking.
  • To discuss the implications of these mechanisms for allograft rejection and tolerance induction.
  • To emphasize the significance of the anatomical context of T cell priming.

Main Methods:

  • Literature review of recent studies on T cell migration and trafficking.
  • Analysis of molecular pathways involved in T cell adhesion, activation, and diapedesis.
  • Examination of the role of sphingosine 1-phosphate signaling in immune cell movement.

Main Results:

  • T cell migration is orchestrated by a complex interplay of cellular processes and molecular signals.
  • Integrins, selectins, chemokines, and sphingosine 1-phosphate receptors are key regulators of T cell trafficking.
  • The timing and location of T cell encounters with antigens and immunosuppressants dictate immune outcomes.

Conclusions:

  • Molecular targets involved in T cell migration offer potential strategies for preventing allograft rejection.
  • Understanding the anatomical context of T cell priming is critical for developing tolerance-inducing therapies.
  • Sphingosine 1-phosphate receptors represent a novel therapeutic target for modulating immune cell trafficking.

Related Concept Videos